Literature DB >> 33914187

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art.

Alfredo Páez-Carpio1, Fernando M Gómez2,3, Gemma Isus Olivé2, Pilar Paredes4, Tarik Baetens3, Enrique Carrero5, Marcelo Sánchez2, Ivan Vollmer2.   

Abstract

Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.

Entities:  

Keywords:  Metastatic lung disease; Non-small cell lung carcinoma; Percutaneous thermal ablation

Year:  2021        PMID: 33914187     DOI: 10.1186/s13244-021-00997-5

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


  94 in total

1.  Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.

Authors:  Hiran C Fernando; Rodney J Landreneau; Sumithra J Mandrekar; Francis C Nichols; Shauna L Hillman; Dwight E Heron; Bryan F Meyers; Thomas A DiPetrillo; David R Jones; Sandra L Starnes; Angelina D Tan; Benedict D T Daly; Joe B Putnam
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

2.  Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?

Authors:  O Seror
Journal:  Diagn Interv Imaging       Date:  2015-05-14       Impact factor: 4.026

3.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 4.  Percutaneous thermal ablation of lung tumors - Radiofrequency, microwave and cryotherapy: Where are we going?

Authors:  J Palussière; V Catena; X Buy
Journal:  Diagn Interv Imaging       Date:  2017-08-24       Impact factor: 4.026

Review 5.  The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.

Authors:  Samdeep K Mouli; Ieva Kurilova; Constantinos T Sofocleous; Robert J Lewandowski
Journal:  AJR Am J Roentgenol       Date:  2017-06-28       Impact factor: 3.959

6.  ACR Appropriateness Criteria® screening for pulmonary metastases.

Authors:  Tan-Lucien H Mohammed; Aqeel Chowdhry; Gautham P Reddy; Judith K Amorosa; Kathleen Brown; Debra Sue Dyer; Mark E Ginsburg; Darel E Heitkamp; Jean Jeudy; Jacobo Kirsch; Heber MacMahon; J Anthony Parker; James G Ravenel; Anthony G Saleh; Rakesh D Shah
Journal:  J Thorac Imaging       Date:  2011-02       Impact factor: 3.000

7.  The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer.

Authors:  Frank C Detterbeck; Kari Chansky; Patti Groome; Vanessa Bolejack; John Crowley; Lynn Shemanski; Catherine Kennedy; Mark Krasnik; Michael Peake; Ramón Rami-Porta
Journal:  J Thorac Oncol       Date:  2016-07-21       Impact factor: 15.609

8.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

Review 9.  Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Fergus Macbeth
Journal:  Thorax       Date:  2014-01-09       Impact factor: 9.139

Review 10.  The Past, Present and Future of Pulmonary Metastasectomy: A Review Article.

Authors:  Francis Park-Yun Cheung; Naveed Zeb Alam; Gavin Michael Wright
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-04-10       Impact factor: 1.520

View more
  5 in total

1.  A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis.

Authors:  Minhtuan Nguyenhuy; Yifan Xu; Julian Maingard; Stephen Barnett; Hong Kuan Kok; Mark Brooks; Ashu Jhamb; Hamed Asadi; Simon Knight
Journal:  Cardiovasc Intervent Radiol       Date:  2022-03-30       Impact factor: 2.797

2.  Factors Associated with Pulmonary Function Changes in Patients Undergoing Microwave Ablation for Pulmonary Ground-Glass Nodules.

Authors:  Weida Wu; Jianyang Peng; Hongbin Gao; Yuanzhen Lin; Qunying Lin; Zhicheng Weng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer.

Authors:  Guanghui Huang; Wenhong Li; Min Meng; Yang Ni; Xiaoying Han; Jiao Wang; Zhigeng Zou; Tiehong Zhang; Jianjian Dai; Zhigang Wei; Xia Yang; Xin Ye
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

4.  Microwave ablation with local pleural anesthesia for subpleural pulmonary nodules: our experience.

Authors:  Liangliang Meng; Bin Wu; Xiao Zhang; Xiaobo Zhang; Yingtian Wei; Xiaodong Xue; Zhongliang Zhang; Xin Zhang; Jing Li; Xiaofeng He; Li Ma; Yueyong Xiao
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

Review 5.  Current trends in image-guided chest interventions.

Authors:  Kenneth K Lau; Karin Steinke; Stephen Reis; Srinivas P Cherukuri; Manfred Cejna
Journal:  Respirology       Date:  2022-06-27       Impact factor: 6.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.